reserve (FFR) for hemodynamic assessment of coronary lesions. Results: In 3 patients, a 2-staged procedure was undertaken with FFR measurements at the time of invasive assessment and TAVI thereafter. In the remaining 2 patients, FFR measurements were performed immediately prior to the TAVI procedure with deferral of percutaneous coronary intervention (PCI) in one and ad hoc PCI in the other patient. All 5 patients had uneventful FFR measurements and procedural TAVI outcomes. One patient with a staged approach noted a significant improvement in symptoms already after PCI. Conclusions: FFR provides an effective and safe strategy to assess hemodynamic significance of coronary lesions in patients with severe AS and concomitant CAD considered for TAVI. 
Introduction
Degenerative aortic stenosis (AS) is the most frequent valvular disease in the elderly Western population [1] . In these patients, coexisting coronary artery disease (CAD) is frequently observed. Indeed, about one third of patients with severe AS undergoing valve surgery have concomitant CAD [2] .
Surgical aortic valve (AV) replacement is considered standard of care for symptomatic AS. Over the last decade, transcatheter AV implantation (TAVI) has become an alternative treatment option for selected high-risk patients with severe AS not amenable to open heart surgery [3] . Concomitant CAD may have a negative impact on postprocedural outcome [4] . In particular, rapid right ventricular pacing may be detrimental in patients with severe CAD. Yet, the necessity of coronary revascularization in the context of TAVI is not fully elucidated. Significant coexisting CAD requires preemptive percutaneous coronary intervention (PCI) in patients considered for TAVI, and among carefully selected patients, PCI proved to be safe in addition to TAVI either as a staged or a concomitant intervention [5] . Fractional flow reserve (FFR) is a well-established technique to determine the hemodynamic significance of intermediate coronary lesions for a strictly ischemia-driven revascularization [6] . A value of 0.75 or less identifies hemodynamic significant lesions with an accuracy of more than 90% and high spatial resolution [6] . Using FFR for guidance of PCI reduces major adverse cardiac events in patients with single-and multi-vessel disease as well as in unstable angina and non-ST segment elevation myocardial infarction [7] . A favorable outcome was also observed after FFR-guided surgical treatment of patients with equivocal left main coronary artery stenosis [8] . Hence, FFRguided PCI for hemodynamic assessment of coronary lesion severity prior to TAVI might reduce major adverse cardiac events and improve procedural and long-term patient outcome. The use of intravenous adenosine to induce maximal hyperemia has been shown to be safe in patients with AS in the context of non-invasive assessments [9] . However, potential adverse effects including bradycardia or asystole as well as an adenosine-induced decrease in diastolic blood pressure compromising coronary blood flow in patients with severe AS have to be considered [10] .
Methods
Here, for the first time, we report a series of 5 patients with severe AS and concomitant CAD considered for TAVI who underwent invasive FFR measurements for coronary lesion assessment. Fractional flow reserve measurements were performed applying the hyperemic pullback technique using the RadiAnalyzer TM with the PressureWire TM Certus TM or the Ilumien TM system with the Wireless PressureWire TM Aeris TM (all St. Jude Medical Inc., St. Paul, Minn., USA). Measurements were performed under hyperemia unless spontaneous values indicated ischemia. Hyperemia was induced by continuous intravenous adenosine infusion (0.14 mg/kg/min) until a steady state in hemodynamics and stable FFR values were noted. An FFR below 0.8 was considered suggestive of significant ischemia [11] . Hemodynamics at baseline and during maximal hyperemia are summarized in table 1 . On the basis of an expected high perioperative morbidity, the Heart Team opted for a transcatheter approach [PARTNER B constellation [12, 13] , Society of Thoracic Surgeons (STS) risk of mortality 4.7%]. FFR was 0.63 both in the intermediate artery and in the mid RCA. PCI with drug-eluting stent deployment (Nobori 3.0 ! 14 and 3.5 ! 24 mm, respectively) was performed on both lesions. FFR following PCI was 0.92 in the RCA. After PCI of the intermediate branch, the patient experienced sudden angina resulting from significant plaque shifting with subtotal occlusion of the ostial LAD. Accordingly, immediate PCI/stenting (Nobori 2.0 ! 14 mm) of the ostial LAD was performed, with a good final angiographic result in the LAD and a final FFR of 0.92 in the intermediate branch. On admission for the planned TAVI procedure after 3 weeks, the patient was free of angina. TAVI was performed and a 29-mm CoreValve prosthesis was implanted. There was no relevant postprocedural pressure gradient with minimal paravalvular aortic regurgitation.
Case Series and Results
Due to 2nd-degree AV block, permanent pacemaker implantation had to be performed 2 days following the procedure. The patient had an uneventful course and was discharged 9 days after TAVI. The patient subsequently made an excellent recovery. He resumed riding his bike after 6 months and remained well at 1-year follow-up.
Case 2: FFR Measurement during Evaluation and Staged Intervention (PCI and TAVI)
An 83-year-old female was admitted for decompensated AS (mean systolic pressure gradient 55 mm Hg, indexed AV area 0.2 cmLeft ventricular systolic function was impaired (left ventricular ejection fraction 43%) with diffuse hypokinesia. Invasive cardiac assessment showed a porcelain aorta and severe AS with a mean systolic pressure gradient of 44 mm Hg. Coronary angiography revealed a good long-term result following PCI in the RCA. Furthermore, mild left main disease was noted, which had no hemodynamic significance as assessed by FFR (0.9). However, there was a 50-70% stenosis of the mid LAD at the bifurcation to the first diagonal branch with a clear step up in FFR from 0.76 to 0.9. In the presence of secondary pulmonary hypertension (systolic pulmonary artery pressure 82 mm Hg) and increased left ventricular end-diastolic pressure (41 mm Hg), the intervention was postponed. After complete evaluation by the Heart Team, TAVI was considered the appropriate therapy (PARTNER B constellation, STS risk of mortality 6.7%). After recompensation, TAVI (implantation of a 23-mm Edwards SAPIEN prosthesis by transfemoral access) combined with PCI including drug-eluting stent deployment (Resolute Integrity 2.75 ! 18 mm) in the mid LAD was performed. Postprocedural aortography revealed good prosthesis function with mild paravalvular aortic regurgitation. The patient had an uneventful course and was discharged after 10 days. At 1-month follow-up, the patient was free of symptoms.
Case 3: FFR-Guided Single-Vessel Intervention and TAVI
An 83-year-old patient with known AS was referred with cardiogenic shock and non-ST segment elevation myocardial infarction. The previous history included hypertension, previous surgical repair of an abdominal aortic aneurysm, and renal transplantation. Echocardiographic workup showed severe AS with a mean systolic pressure gradient of 67 mm Hg and an indexed AV area of 0.3 cm 2 /m 2 . Coronary angiography revealed diffuse multivessel disease with serial 70% stenoses of a small posterior descending artery and chronic occlusion of the small 1st diagonal branch. Foremost, a focal stenosis of borderline angiographic significance in the mid LAD was noted. In view of the critical condition, an intra-aortic balloon pump was placed and the patient transferred to the intensive care unit for hemodynamic stabilization. He was considered for TAVI by the Heart Team based on a high per se perioperative risk (PARTNER A constellation, STS risk of mortality 14.7%).
After 2 days, FFR-guided PCI of the LAD stenosis (spontaneous FFR 0.6) with implantation of a drug-eluting stent (Promus 2.75 ! 18 mm) was performed uneventfully. At the same time, successful transfemoral implantation of a 26-mm Edwards SA-PIEN prosthesis was performed with only mild paravalvular regurgitation on final angiogram. The patient could be discharged after 11 days. During the further course, melena occurred and colorectal adenocarcinoma was diagnosed.
Case 4: Multivessel FFR and Selected PCI during Evaluation before TAVI
An 86-year-old female with squamous cell carcinoma of the tongue and otherwise unremarkable previous history was referred for a systolic murmur noted on preoperative examination. Echocardiography showed severe AS (mean systolic pressure gradient 50 mm Hg, indexed AV area 0.5 cm 2 /m 2 ), and by taking a thorough medical history, shortness of breath on exertion (NYHA class II) over the last 6 months was revealed. In view of her intense pain and the inability to swallow, there was interdisciplinary consensus that she would be best served with urgent neck surgery preceded by aortic intervention, notably TAVI (PARTNER B constellation, STS risk of mortality 7.0%). Coronary angiography showed additional distal left main disease, diffuse disease of the proximal and mid LAD, and a focal borderline stenosis of the RCA. To avoid unnecessary PCI in this setting, FFR was utilized to assess both the left main coronary artery/LAD and the RCA. Interestingly, in both territories, spontaneous FFR under non-hyperemic conditions was below 0.8 already (0.77 and 0.55 in the mid LAD and mid RCA, respectively). However, on pullback, an ischemia-provoking lesion with a clear step up in FFR from 0.55 to 0.83 was only noted in the mid segment of the RCA, whereas the gradual increase in FFR from 0.77 in the mid LAD to 1.0 at the ostium of the left coronary most likely reflected the diffuse disease noted on angiogram ( fig. 1 ) . Accordingly, the left main coronary artery and the LAD were left untreated, and successful PCI of the RCA with implantation of 2 bare-metal stents (Multilink 3.0 ! 28 mm and 3.0 ! 15 mm, respectively) was performed. After PCI, spontaneous FFR in the mid RCA was 1.0 with an insignificant decrease to 0.91 after continuous adenosine administration. Three days after FFR-guided PCI, transfemoral TAVI Case 1  129  48  78  161  43  63  117  41  68  68  Case 2  173  69  104  214  41  72  126  36  66  73  Case 3  93  54  69  145  46  72  85  45  60  62  Case 4  148  40  56  --75  74  67  68  80  Case 5  128  44  73  196  18  57  100  41  58  58 Ao S = Systolic aortic pressure; Ao D = diastolic aortic pressure; Ao M = mean aortic pressure; LV S = systolic left ventricular pressure; LV EDP = left ventricular end-diastolic pressure; HR = heart rate.
with implantation of a 26-mm CoreValve prosthesis was conducted with a final mean systolic pressure gradient of 8 mm Hg, a trace of paravalvular aortic regurgitation, and an uneventful shortterm follow-up.
Case 5: FFR-Based Deferral of PCI during TAVI
An 81-year-old female with a longstandig history of disabling rheumatoid arthritis on methotrexate was admitted to our hospital with severe AS and worsening dyspnea (NYHA class IV). Transthoracic echocardiography showed a mean systolic pressure gradient of 45 mm Hg and an indexed AV area of 0.4 cm 2 /m 2 . A focal 75% stenosis in the RCX as well as irregularities of the proximal LAD and the intermediate branch were documented on coronary angiography. Peak-to-peak transvalvular aortic gradient was 68 mm Hg. After evaluation by the Heart Team, the patient was scheduled for TAVI primarily based on frailty and immobil- ity (PARTNER B constellation, STS risk of mortality 6.4%). Prior to TAVI, the hemodynamic relevance of the RCX lesion was evaluated by FFR, which revealed a minimal value of 0.9. Therefore, no hemodynamic rationality for PCI was proven, and a 29-mm Core Valve prosthesis was implanted in the same sitting. Postprocedural aortography revealed mild paravalvular aortic regurgitation. The course was completely uneventful and the patient was discharged 8 days after the procedure. After 2 months, the patient was free of symptoms, with an increase in functional class from NYHA class IV to I.
Discussion
This case series illustrates the safety and benefits of FFR in the assessment of hemodynamic significance of coronary lesions in patients with severe AS and concomitant CAD considered for TAVI. To the best of our knowledge, FFR measurements in patients with CAD considered for TAVI have not been reported yet.
Cardiovascular diseases, in particular degenerative AS and CAD, are increasingly prevalent in the ageing population [1] . Indeed, moderate to severe AS is present in about 2.8% of over 75-year olds [1] , and in a series of patients aged 60-82 years with calcific AS, significant concomitant CAD was observed in 68% [14] . Accordingly, in patients with severe AS undergoing valve surgery, concomitant CAD was reported in about one third [2] . However, in patients with both severe AS and CAD, AS may be considered to be the leading diagnosis. Notwithstanding, symptoms in patients with severe AS may be caused by significant coronary lesions.
The optimal strategy for coronary revascularization in patients considered for TAVI remains unclear. Current guidelines recommend concomitant coronary artery bypass grafting for significant CAD in patients undergoing conventional AV replacement [15] . Transcatheter AV implantation is indicated in selected high-risk patients unsuitable to open heart surgery, as severe AS rapidly progresses once symptoms have developed, and patients usually die within 2-3 years without treatment [16, 17] . Concomitant CAD may worsen patient outcome following TAVI [4] . Treatment of severe AS may reduce ischemia despite the presence of previously significant CAD. On the other hand, PCI for significant CAD may improve symptoms. Thus, percutaneous revascularization of significant CAD before TAVI should be encouraged comparable to coronary artery bypass grafting in surgical patients. In addition, significant coronary lesions are preferably treated prior to rapid right ventricular pacing which could induce myocardial ischemia, particularly in hypertrophic hearts. However, every additional intervention performed before or during valve implantation has to be balanced against increased periprocedural risk. Indeed, in patients with severe AS, PCI has been associated with poor outcome [18] , and resuscitation outcomes are known to be poor in AS patients [19] . Furthermore, post-TAVI PCI in the presence of percutaneous prosthetic valves may be difficult. Hence, it is important to assess the hemodynamic significance of concomitant CAD.
The FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) study showed that FFR is a valuable tool for physiology-guided lesion assessment, and routine FFR in addition to coronary angiography has improved the outcome of PCI [11] . Deferring PCI in hemodynamically non-significant coronary lesions is safe with an annual rate of cardiac death or myocardial infarction of ! 1% [20] . FFR-guided PCI for hemodynamically significant coronary lesions prior to TAVI might alter the procedural strategy, improving long-term outcome and lowering costs.
In conclusion, this case series illustrates that FFR can be performed safely in different settings, either during evaluation of patients considered for TAVI or combined with PCI and TAVI in an integrated procedure. Furthermore, it can be performed to assess left main CAD in the setting of severe AS. Hence, as highlighted by this case series, FFR is easily applicable and its use might be an option in the assessment of coronary lesions in patients with severe AS and concomitant CAD considered for TAVI.
